Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2014 by CJ HealthCare Corporation.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
CJ HealthCare Corporation
ClinicalTrials.gov Identifier:
NCT02059616
First received: February 10, 2014
Last updated: April 29, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)